FIDELIS CAPITAL PARTNERS, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1962755 TAMPA, FL

Position in BMY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,613,014

-$32,845 QoQ

Shares Held

27,994

+3.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#924

of 2,506 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 87% Shared 0% None 13%

Healthcare · as of Jun 30, 2026

FIDELIS CAPITAL PARTNERS, LLC holds $51,570,809 across 10 Drug Manufacturers - General names. BMY ranks #6 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	55,734	$14,154,763
2	LLY	ELI LILLY & Co	11,461	$13,746,668
3	ABBV	AbbVie Inc.	38,686	$9,734,945
4	MRK	Merck & Co., Inc.	51,693	$6,642,550
5	AMGN	Amgen Inc	8,119	$2,940,052
6	BMY	Bristol Myers Squibb Co This page	27,994	$1,613,014
7	PFE	Pfizer Inc	51,883	$1,249,342
8	GILD	Gilead Sciences, Inc.	6,859	$866,566

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,613,014	27,994	+3.2%	Shares	Sole	2026-08-13
2026-03-31	$1,645,859	27,137	+18.8%	Shares	Sole	2026-05-06
2025-12-31	$1,232,259	22,845	+11.8%	Shares	Sole	2026-02-09
2025-09-30	$921,167	20,425	-6.2%	Shares	Sole	2025-11-03
2025-06-30	$1,008,103	21,778	-5.3%	Shares	Sole	2025-08-07
2025-03-31	$1,402,343	22,993	+78.3%	Shares	Sole	2025-05-01
2024-12-31	$729,284	12,894	+6.7%	Shares	Sole	2025-02-06
2024-09-30	$625,070	12,081	-7.6%	Shares	Sole	2024-10-25
2024-06-30	$542,714	13,068	+85.1%	Shares	Sole	2024-08-13
2024-03-31	$382,918	7,061	+3.5%	Shares	Sole	2024-05-06
2023-12-31	$350,036	6,822	+57.5%	Shares	Sole	2024-01-31
2023-09-30	$251,371	4,331	-31.7%	Shares	Sole	2023-11-08
2023-06-30	$405,762	6,345	+5.3%	Shares	Sole	2023-08-10
2023-03-31	$417,662	6,026	—	Shares	Sole	2023-05-09
No filing history on record for this holder in this stock.